文献速递老年慢病共病管理老年综合评估

血浆脂肪酸谱与多病共存轨迹及死亡风险的关联:一项社区纵向研究

Association of Plasma Fatty Acid Profile With Trajectory of Multimorbidity and Mortality: A Community-Based Longitudinal Study.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2025-01-01

高HFAS与慢性病/死亡风险降低(HR 0.907,95%CI 0.888-0.925)、无事件生存延长0.636年及多病共存累积轨迹减慢(β -0.042,95%CI -0.045至-0.038)相关。

要点

  • 高健康脂肪酸评分与慢性病/死亡风险降低及无事件生存延长相关。
  • 高健康脂肪酸评分与多病共存累积轨迹减慢独立相关。
  • 中高健康脂肪酸评分与健康生活方式存在显著交互作用。

核心结论

  • 更健康的血浆脂肪酸代谢谱与多病共存累积更慢及无事件生存时间延长相关。
  • 健康生活方式可能增强HFAS对慢性病/死亡风险及多病共存累积轨迹的保护性关联。

研究设计与样本

  • 基于英国生物银行的社区纵向研究,纳入138,685名无慢性病参与者,随访至多16年。
  • 通过医疗和死亡记录链接确定慢性病发病和死亡,采用线性混合效应模型、Cox回归和Laplace回归分析。

主要发现

  • 高HFAS与慢性病/死亡风险降低相关(HR 0.907,95%CI 0.888-0.925)。
  • 高HFAS与无事件生存时间延长0.636年相关(95%CI 0.500-0.774)。
  • 高HFAS与多病共存累积轨迹减慢相关(β -0.042,95%CI -0.045至-0.038)。

临床怎么用

  • 在老年社区人群中,可关注血浆脂肪酸谱作为多病共存风险分层的潜在生物标志物。
  • 鼓励健康生活方式可能增强健康脂肪酸谱对慢性病和死亡风险的 protective 关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Plasma fatty acids have been linked to various chronic diseases and mortality, but the extent to which fatty acids are associated with the trajectory of multimorbidity remains unclear. We investigated the association of fatty acid profile with multimorbidity trajectories and event-free survival. METHODS: Within the UK Biobank, 138,685 chronic disease-free participants were followed for up to 16 years. Seventeen plasma fatty acids were measured by nuclear magnetic resonance. A comprehensive healthy fatty acid score (HFAS) was constructed using LASSO regression. Incidence of chronic diseases and death were ascertained through linkages to medical and death records. Event-free survival was defined as survival without chronic diseases or death. Data were analyzed using a linear mixed-effects model, Cox regression, and Laplace regression. RESULTS: High HFAS was associated with lower risk of chronic diseases/death (hazard ratio [HR]: 0.907, 95% confidence interval [CI]: 0.888-0.925) and prolonged event-free survival time by 0.636 (95% CI: 0.500-0.774) years compared with low HFAS. High HFAS was also associated with a slower accumulation trajectory of multimorbidity (β: -0.042, 95% CI: -0.045 to -0.038). There was a significant multiplicative interaction between moderate-to-high HFAS and healthy lifestyle on chronic disease/death (p for interaction = .002) and multimorbidity accumulation trajectories (p for interaction < .001). CONCLUSIONS: A healthier plasma fatty acid metabolic profile is associated with a slower accumulation of multimorbidity and prolonged event-free survival time. A healthy lifestyle may strengthen the protective association of HFAS with the risk of chronic diseases/death and the accumulation trajectory of multimorbidity.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Li Y, Wang J, Miao Y, et al. Association of Plasma Fatty Acid Profile With Trajectory of Multimorbidity and Mortality: A Community-Based Longitudinal Study. J Gerontol A Biol Sci Med Sci. 2025. PMID: 39954290. doi:10.1093/gerona/glaf031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。